or
forgot password

    • cancer clinical trials in battle creek, MI

    • S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Gastric Cancer
    S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Head and Neck Cancer
    Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Breast Cancer, Sexual Dysfunction, Sexuality and Reproductive Issues
    Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Colorectal Cancer, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults, Pain, Psychosocial Effects of Cancer and Its Treatment
    S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Prostate Cancer
    Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Melanoma (Skin)
    Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme
    Battle Creek Health System
    Battle Creek, Michigan 49017
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Breast Cancer
    Cognition in the Study of Tamoxifen and Raloxifene
    Battle Creek Health Systems
    Battle Creek, Michigan 49016
    Cognition, Aging
    SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Lymphoma
    S0309, Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma, Waldenstrom's Macroglobulinemia, Amyloidosis, or Monoclonal Gammopathy of Undetermined Significance
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition
    S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    AMG 386 in Treating Patients With Persistent or Recurrent Endometrial Cancer
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Endometrial Cancer
    Vitamin D and Breast Cancer Biomarkers in Female Patients
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Breast Cancer
    Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia